跳至主要内容
临床试验/NCT00631358
NCT00631358已完成4 期

Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention

Alcon Research2 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2008年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
97
试验地点
2
主要终点
Change in Levels of Biomarkers After Dosing With Maxidex

研究概览

简要总结

The primary purpose of this study is to quantify the change in expression of biomarkers on the ocular surface of Sjogren's Syndrome participants after treatment with Maxidex.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 17 years or older
  • LogMar visual acuity of 0.6 or better
  • Ocular inflammation associated with Sjogren's Syndrome

排除标准

  • Has had an adverse reaction to either topical of systemic steroids in the past
  • Has diabetes (type 1 or 2)
  • Has glaucoma or evidence of ocular hypertension in either eye or treatment of either within six months of Visit 1
  • Has worn contact lenses within one week prior to Visit 1
  • Has received ocular prescription therapy in the last 30 days
  • Has active ocular infections or inflammation not associated with Sjogren's Syndrome.
  • Has any finding in the vitreous, macula, retina or choroid that show signs of inflammation and/or any structural change that in the opinion of the investigator is considered abnormal or unstable for that participant

研究组 & 干预措施

Maxidex

Experimental

Maxidex

干预措施: Maxidex (Drug)

No treatment

Sham Comparator

Healthy normal control group receiving no treatment

干预措施: No treatment (Other)

结局指标

主要结局

Change in Levels of Biomarkers After Dosing With Maxidex

时间窗: Baseline to 2 weeks

Biomarkers are an indicatior of inflammation. In this study, the level of biomarkers before and after anti-inflammatory treatment (Maxidex) is measured for the treatment group. In the control group, the biomarker level is measured at baseline and 2 weeks later. ddCt (Delta-Delta-Ct) is the number of polymerase chain reaction (PCR) cycles required to generate a quantifiable number.

次要结局

  • Correlation Between Biomarker Expression and Ocular Symptoms(Baseline to 2 weeks)
  • Correlation Between Biomarker Expression and Tear Film Break up Time(Baseline to 2 weeks)
  • Correlation Between Biomarker Expression and NaFl (Sodium Fluorescein) Staining(Baseline to 2 weeks)
  • Correlation Between Biomarker Expression and the Schirmer Test(Baseline to 2 weeks)

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验